Načítá se...
High‐throughput screening assays for SARS‐CoV‐2 drug development: Current status and future directions
In response to the ongoing coronavirus disease 2019 (COVID-19) pandemic, a panel of assays has been developed and applied to screen collections of approved and investigational drugs for anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) activity in a quantitative high-throughput scree...
Uloženo v:
| Vydáno v: | Drug Discov Today |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier Science Ltd. ;, Distributed by Virgin Mailing and Distribution
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8146264/ https://ncbi.nlm.nih.gov/pubmed/34048893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2021.05.012 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|